Business Wire

MD-GET-REAL-HEALTH

21.9.2021 15:02:14 CEST | Business Wire | Press release

Share
Get Real Health Announces Further International Expansion to Bring Patient Engagement Tools Into The Netherlands

Get Real Health, a member of the CPSI (NASDAQ: CPSI) family of companies and a provider of comprehensive patient engagement tools, has expanded its international presence through an implementation in the region of Achterhoek, Netherlands, together with local partners MIJNPGO and WeDoTrust.

This implementation is meant to support the region’s ambition to become the healthiest region in the Netherlands by 2030. To that end, the project will have timed implementations and deployments aimed at improving healthcare across all demographics.

The Achterhoek solution is based on Get Real Health’s existing platform, and is customized for the region’s needs and called “MIJNPGO.” This customization effort includes ensuring compliance with Medmij, the technology standard across the Netherlands, which requires the secure exchange of data between care providers and patients. The initial pilot served a select cohort of care organizations including Sensire, the largest elderly care organization in the region. An expanded roll-out will utilize feedback and aim at improving the user experience over time.

“We are thrilled to participate in this important initiative. Our platform perfectly aligns with the mission of Achterhoek with respect to improved healthcare delivery and patient care outcomes both today and into the future,” said Robin Wiener, president of Get Real Health.

“In the Dutch region of Achterhoek, we are constantly working on adding more professional applications of modern technology in healthcare, together with other healthcare organizations and partners,” said Maarten van Rixtel, chief executive officer of Sensire, the largest elderly care organization in the region. “With MIJNPGO, the patients gain more insight into their own health. In addition, patients can share information with healthcare workers or caregivers. MIJNPGO therefore gives patients much more control over their own care and treatment process. This creates equal discussions and certain decisions can be made jointly. For us, MIJNPGO is one of the fundamental bases of healthcare for the future. We are looking forward to the moment when MIJNPGO will be used by many patients.”

Following the initial launch of the pilot in 2020, Get Real Health expanded the release of the platform at the end of August 2021, along with a website design refresh and portal upgrade to improve patient outcomes, enhance health, and implement a more engaging platform to the overall user base.

Through similar deployments in Canada, New Zealand, the Middle East and the United Kingdom, Get Real Health has established itself as an international presence in the patient engagement arena. “We see patient engagement as a global issue, and we develop applications with that philosophy in mind,” explained Wiener. “Our platform is flexible and scalable to serve individuals worldwide.”

About Get Real Health

Get Real Health, a member of the CPSI family of companies, combines a world of new information from patients, devices and apps with existing clinical data to help individuals and healthcare professionals engage and empower each other. By giving providers and patients the information and tools that they need to work together, we help our customers meet their ever-changing patient engagement needs. Our suite of products helps deliver value-based care, improve outcomes, activate patients, and increase patient loyalty and satisfaction, all while meeting regulatory requirements. For more information, visit www.getrealhealth.com .

About WeDoTrust

WeDoTrust is a consultancy and audit company. They assist healthcare institutions, among other things, in drawing up a realistic digital change agenda based on their strategy and financial possibilities. In doing so, they take into account the strength of the organization, market demand and the (im)possibilities of technology.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “projects,” “targets,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the success of Get Real Health’s solutions in the region of Achterhoek, Netherlands, are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: the ability of Get Real Health’s technology and tools to successfully provide patients with more control over their healthcare information and allow greater accessibility to clinical teams and health records; the ability of Get Real Health’s platform to comply with the Medmij technology standard; the impact of the ongoing COVID-19 pandemic and related economic disruptions which have materially affected CPSI’s revenue and could materially affect CPSI’s gross margin and income, as well as CPSI’s financial position and/or liquidity; actions to be taken by CPSI in response to the pandemic; the legal, regulatory and administrative developments that occur at the federal, state and local levels; changes in revenues due to declining hospital demand and deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients); CPSI’s potential inability to attract and retain qualified client service and support personnel, as well as the disruptive effect of sales force restructurings; exposure to numerous laws, regulations and other requirements through CPSI’s international business activities; potential failure to develop or enhance products in response to market demands, as well as undetected errors or problems in new products or enhancements; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of CPSI’s or its partners’ information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; dependence on licenses of rights, products and services from third parties; service interruptions resulting from loss of power and/or telecommunications capabilities; potential increased expenses related to labor or other expenditures; the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms or at all, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financial perspective; and other risk factors described from time to time in CPSI’s public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, CPSI’s most recent Annual Report on Form 10-K. We also caution investors that the forward-looking information described herein represents CPSI’s outlook only as of this date, and CPSI undertakes no obligation to update or revise any forward-looking statements to reflect events or development after the date of this press release.

Link:

ClickThru

Social Media:

https://www.facebook.com/GetRealHealth/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

Credit Derivatives Determinations Committees Membership applications for 202627.3.2026 17:30:00 CET | Press release

DC Administration Services, Inc. (DCAS) would like to invite all interested Members of ISDA to apply for a position as a member of the Credit Derivatives Determinations Committees. There is a separate Determinations Committee for each of the relevant regions. Members of ISDA may apply for membership as either a Dealer Member of the Determinations Committees or a Non-Dealer Member of the Determinations Committees (as applicable). Parties wishing to apply for such a position should carefully review and submit either an executed Dealer Participation Letter (for a prospective Dealer Member) or an executed Non-dealer Committee Participation Letter (for a prospective Non-Dealer Member) by 5pm (New York time) on Friday, April 3, 2026. CCPs may also apply to participate as a CCP Member by submitting a Participating CCP Institution Letter. For more information on the process and to download the form of the relevant letter, please visit https://www.cdsdeterminationscommittees.org/about-dc-commit

Andersen Consulting indgår samarbejdsaftale med Solutia27.3.2026 15:22:00 CET | Pressemeddelelse

Andersen Consulting udvider sin tilstedeværelse i Spanien gennem en samarbejdsaftale med Solutia, en virksomhed med speciale i løsninger inden for arbejdsmiljø og sundhed samt rekruttering inden for life science- og sundhedssektoren. Solutia blev stiftet i 2014 og tilbyder omfattende tjenester og rådgivning med fokus på sunde arbejdsmiljøer, sygefravær, outsourcing af sundhedsydelser og uddannelse til organisationer på tværs af alle sektorer. Virksomheden leverer også rekrutterings- og executive search-løsninger med fokus på life science, tekniske fagfolk samt mellem- og topledelse samt dybdegående ekspertise inden for medicinal-, bioteknologi-, medico- og sundhedsindustrien. Ved hjælp af datadrevne og skræddersyede løsninger hjælper Solutia virksomheder med at optimere medarbejdereffektiviteten og tiltrække specialister. "Vores mål er at forbedre, hvordan organisationer tiltrækker, udvikler og leder medarbejdere i et stadig mere komplekst miljø," udtalte Cesar Castel, administrerende

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye